Search

Your search keyword '"Shide, Kotaro"' showing total 358 results

Search Constraints

Start Over You searched for: Author "Shide, Kotaro" Remove constraint Author: "Shide, Kotaro"
358 results on '"Shide, Kotaro"'

Search Results

1. Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan

3. Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers

4. Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis

5. SDHAF1 confers metabolic resilience to aging hematopoietic stem cells by promoting mitochondrial ATP production

6. Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model

8. CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma

9. Whole-genome landscape of adult T-cell leukemia/lymphoma

12. Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis

18. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma

19. Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia

20. Table S2 from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

21. Supplementary Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

22. Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

25. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan

26. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma

27. Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis

28. Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator

29. Preclinical Translational Research Suggests a Clinical Trial Strategy for a Novel MALT1 Inhibitor ONO-7018/CTX-177 Against Malignant Lymphomas

30. Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers

32. Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma

33. The effect of CARD11 mutation and HBZ expression accelerated lymphoproliferative diseases and formed the pathological basis for adult T-cell leukemia/lymphoma

35. R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm

36. Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

37. Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formation

38. Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, Japan

39. Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki Prefecture

43. Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan

44. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphoma

45. Whole-Genome Analysis of Adult T-Cell Leukemia/Lymphoma

46. Preclinical Evaluation of a Novel MALT1 Inhibitor CTX-177 for Relapse/Refractory Lymphomas

49. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice

50. Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms

Catalog

Books, media, physical & digital resources